DENSURKO
Live / Registered — Registered (as of 10 Oct 2023)
What this means for you
Registered since 10 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97263843
- Registration number
- 7186029
- Mark type
- Stylized text
- Filed
- 11 Feb 2022
- Published for opposition
- 25 Jul 2023
- Registered
- 10 Oct 2023
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 10 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jul 2023 — PUBLISHED FOR OPPOSITION
- 05 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 May 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 May 2023 — ASSIGNED TO LIE
- 08 Feb 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 12 Nov 2022 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED